Perspectives on M&A, valuation, and strategy for consumer, beauty, and healthcare leaders.
Valentine Rufin · 8 April 2026
Most founders have a number in their head. It is almost always wrong. How valuations actually work for EUR 5-50M companies in consumer, beauty, and healthcare — and what drives the number up or down.
Read →Valentine Rufin · 1 April 2026
If your company does EUR 5-50M in revenue in consumer, beauty, or healthcare, you are in the PE sweet spot. Here is what private equity funds actually evaluate — and what PE-ready means in practice.
Read →Valentine Rufin · 25 March 2026
The five business plan mistakes that consistently kill deals or reduce valuations — and how to fix them before a buyer finds them. Practical guidance for EUR 5-50M companies.
Read →